Nom du produit:4-(Boc-amino)piperidine-4-carboxylic acid

IUPAC Name:4-{[(tert-butoxy)carbonyl]amino}piperidine-4-carboxylic acid

CAS:252720-31-3
Formule moléculaire:C11H20N2O4
Pureté:95%+
Numéro de catalogue:CM180270
Poids moléculaire:244.29

Unité d'emballage Stock disponible Prix($) Quantité
CM180270-5g in stock ǕƄ
CM180270-10g in stock ŢǯƄ
CM180270-25g in stock źưź

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:252720-31-3
Formule moléculaire:C11H20N2O4
Point de fusion:-
Code SMILES:O=C(C1(NC(OC(C)(C)C)=O)CCNCC1)O
Densité:
Numéro de catalogue:CM180270
Poids moléculaire:244.29
Point d'ébullition:
N° Mdl:MFCD03790944
Stockage:Keep in dark place, store at 2-8°C.

Category Infos

Amino Acids and Peptides
Amino acids are organic compounds containing a basic amino group and an acidic carboxyl group. Because amino acids contain both amino and carboxyl groups, they can be polymerized in an end-to-end manner, removing a molecule of water to form a covalent amide bond or peptide bond. Many amino acids are linked together end to end to form a polypeptide. Amino acids and peptides are important components in the fields of medicine and life sciences.
amino acids wholesale
if you are finding amino acids wholesaler in china, we will be your best choose! We have our own factory, so we can give you a cheap price!
Piperidines
Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
Piperidine,Piperidine Price
if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

Column Infos

Capivasertib
On November 16, FDA approved Capivasertib for the treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative locally advanced or metastatic breast cancer. Capivasertib is a highly selective inhibitor targeting three AKT subtypes (AKT1/2/3), which can block signals used by cancer cells for division and growth.

Related Products